Dan A. Giampuzzi

Dan A. Giampuzzi

Health Technology
Consumer Services
Finance

Profile

Mr. Giampuzzi most recently served as President and CEO of Gemin X Biotechnologies Inc., a Montreal/Philadelphia-based private biotechnology company that specializes in the discovery and development of novel small molecule cancer therapeutics based on the regulation of apoptosis, the body's natural ability to destroy injured or damaged cells.
During his nine years at Gemin X, he successfully raised over $100 million in private venture capital financing from international firms and assembled a highly capable team that has put over 12 cancer drugs into the clinic and six onto the market today.
Previous to Gemin X he worked in senior management roles for such organizations as MDS Capital Corp., Searle Canada Inc. and Merrell Dow Pharmaceuticals.
Mr. Giampuzzi earned a Bachelor of Science and an MBA from the University of Toronto.

Former positions of Dan A. Giampuzzi

CompaniesPositionEnd
Private Equity Investor 2008-11-30
President 2007-07-30
See the detail of Dan A. Giampuzzi's experience

Training of Dan A. Giampuzzi

University of Toronto Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dan A. Giampuzzi's experience

Connections

17

1st degree connections

3

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies2

Health Technology

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Dan A. Giampuzzi